OtherInflammation and Immunopharmacology
An orally-bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits PGD2-induced eosinophil migration in vitro
Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino, Yoshihisa Manabe, Akihiko Watanabe, Makoto Shimazaki, Florian Gantner and Kevin B Bacon
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.046748
Hiromi Sugimoto
Michitaka Shichijo
Takashi Iino
Yoshihisa Manabe
Akihiko Watanabe
Makoto Shimazaki
Florian Gantner
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherInflammation and Immunopharmacology
An orally-bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits PGD2-induced eosinophil migration in vitro
Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino, Yoshihisa Manabe, Akihiko Watanabe, Makoto Shimazaki, Florian Gantner and Kevin B Bacon
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.046748
OtherInflammation and Immunopharmacology
An orally-bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits PGD2-induced eosinophil migration in vitro
Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino, Yoshihisa Manabe, Akihiko Watanabe, Makoto Shimazaki, Florian Gantner and Kevin B Bacon
Journal of Pharmacology and Experimental Therapeutics January 21, 2003, DOI: https://doi.org/10.1124/jpet.102.046748
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement